4-BROMO-3-CHLOROBENZOIC ACID

We are 4-BROMO-3-CHLOROBENZOIC ACID CAS:25118-59-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-BROMO-3-CHLOROBENZOIC ACID
CAS.NO:25118-59-6
Synonyms:4-BROMO-3-CHLOROBENZOIC ACID
4-bromo-3-chloro-benzoic acid
Benzoic acid, 4-bromo-3-chloro-
Benzoicacid,4-bromo-3-chloro
Molecular Formula:C7H4BrClO2
Molecular Weight:235.46200
 
Physical and Chemical Properties:
Melting point:220-224ºC
 
Specification:
Appearance:White to beige crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

4-BROMO-3-CHLOROBENZOIC ACID


Related News: In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the “Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry”, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. .Indazole-3-carboxylic acid CAS:4498-67-3 In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.4-Chlorophenyl chlorothionoformate CAS:937-64-4 In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.Ácido 3- (trifenil-2-il) fenilborónico CAS:1235876-72-8 Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.

Related Products
Product Name
4-chloropyridine-2-carbonitrile View Details
Allylboronic acid pinacol ester View Details
Trimethylsilyl cyanide View Details
5-Chloro-2-fluorobenzaldehyde manufacturer [dimethylamino-(2,3,4,5,6-pentafluorophenoxy)methylidene]-dimethylazanium,hexafluorophosphate manufacturer 3-Fluoro-2-Formylphenylboronic Acid manufacturer 2-Fluoro-6-methylbenzaldehyde manufacturer 4-Aminopyrazolo[3,4-d]pyrimidine manufacturer